The complement-binding and absorptive capacity of human white blood cells treated with neuraminidase.
D000818:Animals; D000937:Antigen-Antibody Reactions; D001666:Binding Sites, Antibody; D002462:Cell Membrane / Q000276:immunology; D003168:Complement Fixation Tests; D003165:Complement System Proteins; D003601:Cytotoxicity Tests, Immunologic; D006087:Graft vs Host Reaction / Q000187:drug effects*; D006649:Histocompatibility Antigens; D006801:Humans; D007106:Immune Sera; D066298:In Vitro Techniques; D008214:Lymphocytes / Q000187:drug effects* / Q000276:immunology; D008722:Methods; D009439:Neuraminidase / Q000494:pharmacology*; D011817:Rabbits / Q000276:immunology; D014688:Venoms / Q000494:pharmacology; D014733:Vibrio
D006649:Histocompatibility Antigens; D007106:Immune Sera; D014688:Venoms; D003165:Complement System Proteins; D009439:Neuraminidase